127 related articles for article (PubMed ID: 22361637)
1. [Adherence to a population-based colorectal cancer screening program in Catalonia (Spain), 2000-2008].
Milà N; García M; Binefa G; Borràs JM; Espinàs JA; Moreno V
Gac Sanit; 2012; 26(3):217-22. PubMed ID: 22361637
[TBL] [Abstract][Full Text] [Related]
2. Factors related to longitudinal adherence in colorectal cancer screening: qualitative research findings.
Benito L; Farre A; Binefa G; Vidal C; Cardona A; Pla M; García M
Cancer Causes Control; 2018 Jan; 29(1):103-114. PubMed ID: 29170881
[TBL] [Abstract][Full Text] [Related]
3. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain).
Peris M; Espinàs JA; Muñoz L; Navarro M; Binefa G; Borràs JM;
J Med Screen; 2007; 14(2):81-6. PubMed ID: 17626707
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with initial participation in a population-based screening for colorectal cancer in Catalonia, Spain: a mixed-methods study.
García M; Borràs JM; Milà N; Espinàs JA; Binefa G; Fernández E; Farré A; Pla M; Cardona A; Moreno V
Prev Med; 2011; 52(3-4):265-7. PubMed ID: 21295061
[TBL] [Abstract][Full Text] [Related]
5. [Evaluating colorectal cancer screening strategies (immunological test vs biochemical test) in Catalonia, Spain 2008-2010].
García Martínez M; Binefa Rodríguez G; Milà Díaz N; Rodríguez Moranta F; Gonzalo Diego N; Muñoz Sánchez C; Espinàs Piñol JA; Borràs Andrés JM; Moreno Aguado V
Rev Esp Salud Publica; 2011 Dec; 85(6):593-602. PubMed ID: 22249590
[TBL] [Abstract][Full Text] [Related]
6. Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain.
Garcia M; Borràs JM; Binefa G; Milà N; Espinàs JA; Moreno V
Eur J Cancer Prev; 2012 Jan; 21(1):42-5. PubMed ID: 21849903
[TBL] [Abstract][Full Text] [Related]
7. Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test.
van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
J Public Health (Oxf); 2008 Dec; 30(4):461-5. PubMed ID: 18716047
[TBL] [Abstract][Full Text] [Related]
8. [Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies].
Burón A; Grau J; Andreu M; Augé JM; Guayta-Escolies R; Barau M; Macià F; Castells A;
Med Clin (Barc); 2015 Aug; 145(4):141-6. PubMed ID: 25073826
[TBL] [Abstract][Full Text] [Related]
9. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
[TBL] [Abstract][Full Text] [Related]
10. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
11. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network.
Young WF; McGloin J; Zittleman L; West DR; Westfall JM
J Rural Health; 2007; 23(3):238-45. PubMed ID: 17565524
[TBL] [Abstract][Full Text] [Related]
12. [Colorectal cancer in a population with a guaiac-based screening programme].
Navarro M; Peris M; Binefa G; Vanaclocha M; Losa F; Fernández E
Med Clin (Barc); 2009 Apr; 132(13):495-500. PubMed ID: 19356774
[TBL] [Abstract][Full Text] [Related]
13. Psychosocial factors associated with the adherence to a colorectal cancer screening program.
Gili M; Roca M; Ferrer V; Obrador A; Cabeza E
Cancer Detect Prev; 2006; 30(4):354-60. PubMed ID: 16963195
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with adherence to fecal occult blood testing for colorectal cancer screening among adults in the Republic of Korea.
Bae N; Park S; Lim S
Eur J Oncol Nurs; 2014 Feb; 18(1):72-7. PubMed ID: 24183583
[TBL] [Abstract][Full Text] [Related]
15. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
Inadomi JM
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Colorectal Cancer Screening Participation in Southern Khorasan (Iran).
Ramazani AA; Norozi E; AmirabadiZadeh H; Ehteshampour AR; Salehiniya H
J Gastrointest Cancer; 2021 Mar; 52(1):187-191. PubMed ID: 32125621
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
18. Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.
Guiriguet C; Pera G; Castells A; Toran P; Grau J; Rivero I; Buron A; Macià F; Vela-Vallespín C; Vilarrubí-Estrella M; Marzo-Castillejo M
BMC Cancer; 2017 Aug; 17(1):524. PubMed ID: 28784093
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing participation in colorectal cancer screening programs in Spain.
Vanaclocha-Espi M; Ibáñez J; Molina-Barceló A; Pérez E; Nolasco A; Font R; Pérez-Riquelme F; de la Vega M; Arana-Arri E; Oceja M; Espinàs JA; Portillo I; Salas D;
Prev Med; 2017 Dec; 105():190-196. PubMed ID: 28887191
[TBL] [Abstract][Full Text] [Related]
20. Use of interactive voice response to improve colorectal cancer screening.
Cohen-Cline H; Wernli KJ; Bradford SC; Boles-Hall M; Grossman DC
Med Care; 2014 Jun; 52(6):496-9. PubMed ID: 24638119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
